US startup to test small-dose COVID vaccine in Japan this summer,

VLP aims to move on to a phase two study as early as the end of this year, then conduct a large-scale phase three trial in 2022. If the clinical trials go …, VLP aims to move on to a phase two study as early as the end of this year, then conduct a large-scale phase three trial in 2022. If the clinical trials go …, Read More

Scroll to Top